AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 223.38 billion as of August 15, 2025. Its market cap has decreased by -15.03% in one year.

Market Cap

223.38B

Enterprise Value

206.43B

Revenue

3.11B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,310.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 223.38B, a decrease of -47.23%. That is a compound annual growth rate of -9.83%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	223.38B	30.46%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	563.64B	49.70%
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.52T
Celltrion	38.58T
ALTEOGEN	23.35T
Yuhan	8,561.74B
Peptron	8,235.61B
SK Biopharmaceuticals	7,878.31B
PharmaResearch	7,106.52B
LigaChem Biosciences	5,666.20B

Market Cap Rankings